Skip to main content
. 2023 Jul 28;12:61–71. doi: 10.14283/jarlife.2023.11

Figure 1.

Figure 1.

Decrease in A. HbA1c; B. Glycated albumin (GA); significantly greater in Group I (AFO-202 beta glucan) compared to Group II (AFO-202+N-163 beta glucan); Decrease in C. total cholesterol (T-Cho) and; D. LDL-cholesterol significantly greater in Group II (AFO-202+N-163 beta glucan) compared to Group I (AFO-202 beta glucan)